The ADC binds Trop-2 (not TOP1), is internalized, and releases SN-38, which inhibits topoisomerase I to cause DNA damage and apoptosis. TOP1 is the intracellular enzymatic target of the payload, not the targeted antigen; any killing of TOP1-expressing cells occurs only after Trop-2–mediated delivery (with possible bystander effect).